Trial Details

COMPLETED
Basic Information
Clinical ID c4611
Identifier NCT00261976
Trial Title A Long-term Safety Study of Infliximab (Remicade)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Arthritis, Rheumatoid|Crohn Disease|Psoriasis
Interventions DRUG: Infliximab (Remicade)
Participant Information
Sponsor Centocor, Inc.
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2002-02
Primary Completion Date 2012-03
Completion Date 2012-03